{"id":"https://openalex.org/W2074170446","doi":"https://doi.org/10.3109/00207450903389362","title":"The Angiotensin II Type 1 Receptor Antagonist Olmesartan Preserves Cerebral Blood Flow and Cerebrovascular Reserve Capacity, and Accelerates Rehabilitative Outcomes in Hypertensive Patients with a History of Stroke","display_name":"The Angiotensin II Type 1 Receptor Antagonist Olmesartan Preserves Cerebral Blood Flow and Cerebrovascular Reserve Capacity, and Accelerates Rehabilitative Outcomes in Hypertensive Patients with a History of Stroke","publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W2074170446","doi":"https://doi.org/10.3109/00207450903389362","mag":"2074170446","pmid":"https://pubmed.ncbi.nlm.nih.gov/20402577"},"language":"en","primary_location":{"id":"doi:10.3109/00207450903389362","doi":"https://doi.org/10.3109/00207450903389362","is_oa":false,"landing_page_url":"https://doi.org/10.3109/00207450903389362","pdf_url":null,"source":{"id":"https://openalex.org/S78190159","display_name":"International Journal of Neuroscience","issn_l":"0020-7454","issn":["0020-7454","1026-7085","1543-5245","1563-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuroscience","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101647861","display_name":"Shuji Matsumoto","orcid":"https://orcid.org/0000-0002-6305-6381","observed_orcids":["https://orcid.org/0000-0002-6305-6381"]},"institutions":[{"id":"https://openalex.org/I107139324","display_name":"Kagoshima University","ror":"https://ror.org/03ss88z23","country_code":"JP","type":"education","lineage":["https://openalex.org/I107139324"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shuji Matsumoto","raw_affiliation_strings":["Department of Rehabilitation and Physical Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rehabilitation and Physical Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan","institution_ids":["https://openalex.org/I107139324"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062619981","display_name":"Megumi Shimodozono","orcid":"https://orcid.org/0009-0002-9912-665X","observed_orcids":["https://orcid.org/0009-0002-9912-665X"]},"institutions":[{"id":"https://openalex.org/I107139324","display_name":"Kagoshima University","ror":"https://ror.org/03ss88z23","country_code":"JP","type":"education","lineage":["https://openalex.org/I107139324"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Megumi Shimodozono","raw_affiliation_strings":["Department of Rehabilitation and Physical Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rehabilitation and Physical Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan","institution_ids":["https://openalex.org/I107139324"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081811611","display_name":"Ryuji Miyata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I107139324","display_name":"Kagoshima University","ror":"https://ror.org/03ss88z23","country_code":"JP","type":"education","lineage":["https://openalex.org/I107139324"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryuji Miyata","raw_affiliation_strings":["Department of Rehabilitation and Physical Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rehabilitation and Physical Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan","institution_ids":["https://openalex.org/I107139324"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108744487","display_name":"Kazumi Kawahira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I107139324","display_name":"Kagoshima University","ror":"https://ror.org/03ss88z23","country_code":"JP","type":"education","lineage":["https://openalex.org/I107139324"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazumi Kawahira","raw_affiliation_strings":["Department of Rehabilitation and Physical Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rehabilitation and Physical Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan","institution_ids":["https://openalex.org/I107139324"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101647861"],"corresponding_institution_ids":["https://openalex.org/I107139324"],"apc_list":null,"apc_paid":null,"fwci":0.9582,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.75784709,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"120","issue":"5","first_page":"372","last_page":"380"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.19089999794960022,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.19089999794960022,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.14390000700950623,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14144","display_name":"Neurological Disease Mechanisms and Treatments","score":0.10279999673366547,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olmesartan","display_name":"olmesartan","score":1.0},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9490000009536743},{"id":"https://openalex.org/keywords/cerebral-blood-flow","display_name":"cerebral blood flow","score":0.953000009059906},{"id":"https://openalex.org/keywords/cerebrovascular-reserve","display_name":"cerebrovascular reserve","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cerebral-hemodynamics","display_name":"cerebral hemodynamics","score":0.777999997138977},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.328000009059906},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.972000002861023},{"id":"https://openalex.org/keywords/cerebral-autoregulation","display_name":"cerebral autoregulation","score":0.7129999995231628},{"id":"https://openalex.org/keywords/stroke-rehabilitation","display_name":"stroke rehabilitation","score":0.6159999966621399},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.6980000138282776}],"concepts":[{"id":"https://openalex.org/C2779766728","wikidata":"https://www.wikidata.org/wiki/Q421156","display_name":"Olmesartan","level":3,"score":0.9729785919189453},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7992419004440308},{"id":"https://openalex.org/C157767197","wikidata":"https://www.wikidata.org/wiki/Q886843","display_name":"Cerebral blood flow","level":2,"score":0.7168655395507812},{"id":"https://openalex.org/C111774379","wikidata":"https://www.wikidata.org/wiki/Q1364253","display_name":"Autoregulation","level":3,"score":0.6363105177879333},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.6098725199699402},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.5459259748458862},{"id":"https://openalex.org/C2780708007","wikidata":"https://www.wikidata.org/wiki/Q285044","display_name":"Angiotensin II receptor antagonist","level":5,"score":0.531721830368042},{"id":"https://openalex.org/C104849204","wikidata":"https://www.wikidata.org/wiki/Q24778533","display_name":"Angiotensin receptor","level":4,"score":0.5284735560417175},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5099934339523315},{"id":"https://openalex.org/C178853913","wikidata":"https://www.wikidata.org/wiki/Q1642137","display_name":"Hemodynamics","level":2,"score":0.5073766112327576},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4806205630302429},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.451608270406723},{"id":"https://openalex.org/C119671327","wikidata":"https://www.wikidata.org/wiki/Q886843","display_name":"Cerebral circulation","level":2,"score":0.4278395175933838},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3887014389038086},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000071939","descriptor_name":"Stroke Rehabilitation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000086","descriptor_name":"Acetazolamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006439","descriptor_name":"Hemodynamics","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012039","descriptor_name":"Regional Blood Flow","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3109/00207450903389362","doi":"https://doi.org/10.3109/00207450903389362","is_oa":false,"landing_page_url":"https://doi.org/10.3109/00207450903389362","pdf_url":null,"source":{"id":"https://openalex.org/S78190159","display_name":"International Journal of Neuroscience","issn_l":"0020-7454","issn":["0020-7454","1026-7085","1543-5245","1563-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuroscience","raw_type":"journal-article"},{"id":"pmid:20402577","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20402577","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International journal of neuroscience","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W123061629","https://openalex.org/W563352529","https://openalex.org/W636307681","https://openalex.org/W1847168837","https://openalex.org/W1964564191","https://openalex.org/W1966000112","https://openalex.org/W1971737355","https://openalex.org/W1971914736","https://openalex.org/W1990276611","https://openalex.org/W1995861586","https://openalex.org/W2003904775","https://openalex.org/W2011343589","https://openalex.org/W2019184934","https://openalex.org/W2023635006","https://openalex.org/W2027259772","https://openalex.org/W2036695904","https://openalex.org/W2047607042","https://openalex.org/W2049801530","https://openalex.org/W2053668511","https://openalex.org/W2058689321","https://openalex.org/W2080360981","https://openalex.org/W2088856242","https://openalex.org/W2093385386","https://openalex.org/W2101830541","https://openalex.org/W2113554954","https://openalex.org/W2123714051","https://openalex.org/W2128329080","https://openalex.org/W2153034914","https://openalex.org/W2155777324","https://openalex.org/W2169742106","https://openalex.org/W2192395463","https://openalex.org/W2315383579"],"related_works":["https://openalex.org/W2045999897","https://openalex.org/W2077310274","https://openalex.org/W2064320828","https://openalex.org/W2745763099","https://openalex.org/W2036695904","https://openalex.org/W2086900537","https://openalex.org/W4241185309","https://openalex.org/W4315709589","https://openalex.org/W2064954512","https://openalex.org/W126921385"],"abstract_inverted_index":{"We":[0],"aimed":[1],"to":[2],"determine":[3],"the":[4,40,49,58,67],"effects":[5,85],"of":[6,23,48,57],"angiotensin":[7],"II":[8],"receptor":[9],"blocker":[10],"on":[11],"cerebral":[12,43,98],"hemodynamics":[13],"and":[14,51,91,95,100],"rehabilitative":[15,75,101],"outcome.":[16,102],"Sixteen":[17],"hypertensive":[18,87],"patients":[19,88],"with":[20,39,89],"a":[21],"history":[22],"stroke":[24,90],"received":[25],"10-20":[26],"mg":[27],"olmesartan":[28,82],"daily":[29],"for":[30],"eight":[31],"weeks.":[32],"Blood":[33],"pressure":[34],"decreased":[35],"after":[36],"treatment":[37],"compared":[38],"baseline,":[41],"whereas":[42],"blood":[44],"flow":[45],"(CBF)":[46],"values":[47],"affected":[50,68],"nonaffected":[52],"sides":[53],"increased.":[54],"The":[55],"results":[56],"cerebrovascular":[59],"reserve":[60],"capacity":[61],"were":[62,71],"also":[63],"statistically":[64],"increased":[65],"in":[66,73,86],"side.":[69],"Improvements":[70],"observed":[72],"three":[74],"outcome":[76],"parameters.":[77],"These":[78],"findings":[79],"suggest":[80],"that":[81],"has":[83],"beneficial":[84],"impaired":[92],"CBF":[93],"autoregulation,":[94],"might":[96],"improve":[97],"circulation":[99]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}